ascorbic acid; biotin; cyanocobalamin; dexpanthenol; ergocalciferol; folic acid; niacinamide; phytonadione; pyridoxine hydrochloride; riboflavin 5'-phosphate sodium; thiamine hydrochloride; vitamin a; vitamin e
Drug data last refreshed 1w ago · AI intelligence enriched 2w ago
M.V.I. PEDIATRIC is an intravenous multivitamin formulation containing 13 essential vitamins (A, B-complex, C, D, E, and K) designed for pediatric patients unable to obtain adequate nutrition orally. It is indicated for nutritional supplementation in pediatric populations requiring parenteral nutrition support. The product works by delivering water- and fat-soluble vitamins essential for metabolic function, immune support, and growth in vulnerable pediatric populations.
Established brand approaching loss of exclusivity with moderate competitive pressure (30%), suggesting focus on lifecycle extension, cost management, and clinical differentiation rather than growth initiatives.
Mechanism of action data is being enriched from DailyMed and FDA sources. Check back soon for updated drug intelligence.
Indication data is being enriched from DailyMed and FDA labeling. Check back soon for approved therapeutic uses.
Working on M.V.I. PEDIATRIC offers exposure to mature brand management, supply chain optimization, and cost-containment strategies in a LOE-approaching product. Career growth depends on driving operational excellence and generic defense rather than innovation-focused projects.
Worked on M.V.I. PEDIATRIC at Pfizer? Share your interview experience or compensation data (+7 days Pro)
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
2 open roles linked to this drug